داروسازی امین
دامین | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: 15,280
Balance Sheet
AGM
Interim
2026/02/28 Fiscal Year 2025/12/2112 Month | 2025/07/09 Fiscal Year 2025/03/2012 Month | 2024/06/10 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 5.207 Trillion | 351.326 Billion | 1.963 Trillion | |
Short-Term Investments | 6.2 Billion | 6.2 Billion | 6.2 Billion | |
Trade Receivables | 9.551 Trillion | 11.352 Trillion | 9.484 Trillion | |
Prepayments | 780.941 Billion | 690.177 Billion | - | |
Orders & Prepayments | - | - | 1.957 Trillion | |
Raw Materials & Packaging Inventory | 3.011 Trillion | 3.791 Trillion | 3 Trillion | |
Work-in-Progress Inventory | 421.175 Billion | 256.659 Billion | 175.417 Billion | |
Finished Goods Inventory | 459.995 Billion | 1.018 Trillion | 544.388 Billion | |
Spare Parts Inventory | 60.876 Billion | 42.304 Billion | 38.307 Billion | |
Goods in Transit | - | 301.746 Billion | 347.404 Billion | |
Our Goods on Consignment with Others | 971.323 Billion | 279.241 Billion | 149.526 Billion | |
Inventories | 4.924 Trillion | 5.689 Trillion | 4.255 Trillion | |
Total Current Assets | 20.47 Trillion | 18.089 Trillion | 17.666 Trillion | |
Long-Term Investments | 108.15 Billion | 108.15 Billion | 69.85 Billion | |
Long-Term Trade Receivables | - | 10 Million | 89 Million | |
Intangible Assets | 2.33 Billion | 2.751 Billion | 2.538 Billion | |
Property, Plant & Equipment | 6.025 Trillion | 4.926 Trillion | 4.464 Trillion | |
Net Fixed Assets | 6.025 Trillion | 4.926 Trillion | 4.464 Trillion | |
Total Non-Current Assets | 6.136 Trillion | 5.037 Trillion | 4.536 Trillion | |
Total Assets | 26.605 Trillion | 23.125 Trillion | 22.202 Trillion | |
Trade Payables | 2.871 Trillion | 2.017 Trillion | 1.422 Trillion | |
Advances Received | 1.962 Trillion | 303.731 Billion | 77 Million | |
Income Tax Provision | 410.151 Billion | 390.072 Billion | 845.743 Billion | |
Other Provisions | 128.165 Billion | 152.877 Billion | 41.945 Billion | |
Proposed & Payable Dividends | 163.623 Billion | 163.19 Billion | 126.69 Billion | |
Current Borrowings | 7.243 Trillion | 8.803 Trillion | 8.702 Trillion | |
Total Current Liabilities | 12.778 Trillion | 11.83 Trillion | 11.138 Trillion | |
Long-Term Payables | 35.741 Billion | 28.629 Billion | 19.964 Billion | |
Long-Term Borrowings | 2 Trillion | 129.848 Billion | 239.961 Billion | |
Employee Termination Benefits Provision | 87.608 Billion | 145.068 Billion | 114.31 Billion | |
Total Non-Current Liabilities | 2.123 Trillion | 303.545 Billion | 374.235 Billion | |
Total Liabilities | 14.901 Trillion | 12.134 Trillion | 11.512 Trillion | |
Capital | 9.13 Trillion | 5.5 Trillion | 5.5 Trillion | |
Retained Earnings | 2.01 Trillion | 4.968 Trillion | 4.723 Trillion | |
Legal Reserve | 564.939 Billion | 523.506 Billion | 466.654 Billion | |
Total Equity | 11.705 Trillion | 10.991 Trillion | 10.69 Trillion | |
Total Liabilities & Equity | 26.605 Trillion | 23.125 Trillion | 22.202 Trillion | |
Approved Capital | 9.13 Trillion | 5.5 Trillion | 5.5 Trillion | |
Approved Retained Earnings | 1.836 Trillion | 4.852 Trillion | 4.173 Trillion | |
Approved Legal Reserve | 564.939 Billion | 523.506 Billion | 466.654 Billion | |
Total Approved Equity (at AGM) | 11.531 Trillion | 10.876 Trillion | 10.14 Trillion |
